Lumateperone tosylate, A Selective and Concurrent Modulator of Serotonin, Dopamine, and Glutamate, in the Treatment of Schizophrenia
# Purpose of Review This is a comprehensive review of the literature regarding the use of Lumateperone tosylate for schizophrenia. This review presents the background, evidence, and indications for the use of lumateperone tosylate in the treatment of schizophrenia. # Recent Findings Schizophreni...
Saved in:
Main Authors: | Kunal Maini, Janice W. Hollier, Haley Gould, Victoria Bollich, John LaForge, Elyse M. Cornett, Amber N. Edinoff, Adam M. Kaye, Alan D. Kaye |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Medical Publishing
2021-06-01
|
Series: | Health Psychology Research |
Online Access: | https://doi.org/10.52965/001c.24932 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selective Serotonin Reuptake Inhibitors and Associated Bleeding Risks: A Narrative and Clinical Review
by: Amber N. Edinoff, et al.
Published: (2022-11-01) -
Phenothiazines and their Evolving Roles in Clinical Practice: A Narrative Review
by: Amber N. Edinoff, et al.
Published: (2022-11-01) -
Linezolid and serotonin syndrome
by: Haytham A. Wali
Published: (2025-02-01) -
Methamphetamine Use: A Narrative Review of Adverse Effects and Related Toxicities
by: Amber N. Edinoff, et al.
Published: (2022-09-01) -
Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors
by: Amber N. Edinoff, et al.
Published: (2022-11-01)